PMDD Treatment Guidelines: A Clinical Overview
Premenstrual dysphoric disorder affects an estimated 3 to 8% of menstruating women, and treatment approaches have become far more evidence-based over the past two decades, moving away from a…
Advanced, personalized care for depression that has not responded to previous treatment, for patients across New Jersey and New York.
Self-pay practice · Superbill provided for out-of-network reimbursement
If you have tried antidepressants without lasting relief, you are not out of options. Treatment-resistant depression, also called refractory depression, means depression that has not improved after adequate trials of at least two different medications. It calls for a more advanced, personalized approach rather than simply trying more of the same. After a thorough evaluation, you receive a plan built around your specific history, symptoms, and any co-occurring conditions.
Treatment-resistant depression is diagnosed when depressive symptoms persist after adequate trials of at least two different classes of antidepressant. Evaluation looks at your full treatment history, dosages, and how long each was tried, and rules out factors that can mimic resistance, such as poor absorption or drug interactions. I also assess for co-occurring conditions like anxiety, bipolar disorder, or substance use that can complicate recovery and change the plan.
Getting the diagnosis right is the foundation of effective care. I review your history of antidepressant trials, symptom timeline, and any conditions that may contribute, including chronic pain, trauma, or cognitive difficulties. Using current clinical guidelines and research from trusted sources such as the National Institute of Mental Health, I identify what has been missed and where a different approach is likely to help.
Sometimes the answer is a different class of antidepressant or a carefully chosen combination. Options include SSRIs, SNRIs, and, in select cases, older classes such as tricyclic antidepressants. Augmentation, adding a second medication such as an atypical antipsychotic or mood stabilizer to boost an antidepressant, can help when a single medication is not enough. Each change is monitored closely for response and side effects.
When medication alone has not worked, other evidence-based treatments may be considered. Intranasal esketamine, an FDA-approved nasal spray, can provide rapid relief for some people. Brain stimulation approaches such as repetitive transcranial magnetic stimulation and, in severe cases, electroconvulsive therapy have strong evidence for treatment-resistant depression. I discuss which options fit your situation and coordinate referrals where a treatment is delivered in a specialized setting.
⚠ This content is for informational purposes only. No medication should be started, stopped, or changed without guidance from a qualified psychiatric provider. All treatment decisions at Gimel Health are made following a comprehensive in-person or telehealth evaluation with Michael Feldman, PA-C.
Six focus areas. Click any to see the full approach.
Treatment for depression, bipolar, PMDD, and
complex mood patterns.
Specialized care for chronic worry, panic, PTSD,
and obsessive thoughts.
Treatment for depression, bipolar, PMDD, and
complex mood patterns.
Medical and medication support for anorexia,
bulimia, and binge eating.
Treatment for insomnia, rage, and impulse
control challenges.
Treatment-resistant cases, psychosis,
schizoaffective, autism spectrum.
Three steps. No surprises.
Tell me what's going on. I'll tell you if I'm
the right fit — or refer you to someone
who is.
Full clinical assessment.
We review full medical & psychiatric history, prior treatments, symptoms and
goals together.
Medication plan, dosage refinement, and
regular check-ins.
Founder · Physician Assistant–Certified
Most psychiatric prescribing is trial-and-error. My background in
molecular biology — MSc from Hebrew University of Jerusalem, with
research at the Weizmann Institute and Mt Sinai — lets me think about
your case at the level of biological pathways, not just symptom
checklists. That means fewer wasted medication trials and a clearer
rationale for every decision.
Adults, adolescents, and children with anxiety, depression, ADHD,
bipolar disorder, OCD, eating disorders, and complex or treatment-
resistant cases. I work especially well with patients who've been let
down by rushed 15-minute medication checks elsewhere.
A 60-minute initial evaluation — in person at my Fort Lee office or via
telehealth anywhere in NJ or NY. We'll go through your full history,
current symptoms, prior treatments, and biological context. You leave
with a clear diagnosis and a specific medication plan, not a maybe.
FOUNDER VIDEO
Watch: Why I founded Gimel Health
I don't bill insurance directly, and that's intentional. Insurance-driven psychiatry means short appointments, rigid formularies, and a provider who barely knows your case. This practice is self-pay so I can give you full evaluations and make medication decisions based on what's right for your biology, not what's on the insurer's approved list. Most patients with out-of-network benefits recover 50–80% of fees by submitting the detailed superbill I provide at every visit.
Things patients usually want to know before reaching out.
I personally read every inquiry and respond within one business day.